ID
41201
Beschreibung
A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01263704
Link
https://clinicaltrials.gov/show/NCT01263704
Stichworte
Versionen (1)
- 12.07.20 12.07.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
12. Juli 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Lymphocytic Leukemia, Chronic NCT01263704
Eligibility Lymphocytic Leukemia, Chronic NCT01263704
- StudyEvent: Eligibility
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschreibung
Prior Therapy Chronic Lymphocytic Leukemia
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0023434
Beschreibung
Chronic Lymphocytic Leukemia | Richter's syndrome
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0023434
- UMLS CUI [2]
- C0349631
Beschreibung
Central Nervous System Involvement Chronic Lymphocytic Leukemia Suspected | Central Nervous System Involvement Chronic Lymphocytic Leukemia
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C4050309
- UMLS CUI [1,2]
- C0023434
- UMLS CUI [1,3]
- C0750491
- UMLS CUI [2,1]
- C4050309
- UMLS CUI [2,2]
- C0023434
Beschreibung
Renal Insufficiency | Liver Dysfunction
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1565489
- UMLS CUI [2]
- C0086565
Beschreibung
HIV Seropositivity | Hepatitis B | Hepatitis C | Hepatitis B surface antigen positive | Communicable Disease | Communicable Disease Uncontrolled
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0019163
- UMLS CUI [3]
- C0019196
- UMLS CUI [4]
- C0149709
- UMLS CUI [5]
- C0009450
- UMLS CUI [6,1]
- C0009450
- UMLS CUI [6,2]
- C0205318
Beschreibung
Antibody to hepatitis B core antigen | Hepatitis B In the past | Hepatitis B surface antigen negative | Hepatitis B surface antibody positive | Hepatitis B surface antigen negative | Hepatitis B DNA Positive Polymerase Chain Reaction
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0312631
- UMLS CUI [2,1]
- C0019163
- UMLS CUI [2,2]
- C1444637
- UMLS CUI [3]
- C0919711
- UMLS CUI [4]
- C0149708
- UMLS CUI [5]
- C0919711
- UMLS CUI [6,1]
- C5206277
- UMLS CUI [6,2]
- C0032520
Beschreibung
Comorbidity Requirement Steroid therapy chronic
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C1514873
- UMLS CUI [1,3]
- C0149783
- UMLS CUI [1,4]
- C0205191
Beschreibung
Second Primary Cancer | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of female breast | Exception Carcinoma in situ of prostate
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0751623
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0699893
- UMLS CUI [3,1]
- C1705847
- UMLS CUI [3,2]
- C0851140
- UMLS CUI [4,1]
- C1705847
- UMLS CUI [4,2]
- C0686288
- UMLS CUI [5,1]
- C1705847
- UMLS CUI [5,2]
- C0154088
Beschreibung
ECOG performance status
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1520224
Ähnliche Modelle
Eligibility Lymphocytic Leukemia, Chronic NCT01263704
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0332155 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,2])
C0349631 (UMLS CUI [2])
C0023434 (UMLS CUI [1,2])
C0750491 (UMLS CUI [1,3])
C4050309 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0086565 (UMLS CUI [2])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0149709 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C0009450 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
C0019163 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
C0919711 (UMLS CUI [3])
C0149708 (UMLS CUI [4])
C0919711 (UMLS CUI [5])
C5206277 (UMLS CUI [6,1])
C0032520 (UMLS CUI [6,2])
C1514873 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,3])
C0205191 (UMLS CUI [1,4])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0686288 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0154088 (UMLS CUI [5,2])